Strategy Asset Managers’s Edwards Lifesciences EW Stock Holding History

Strategy Asset Managers’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,421	Closed	-$312K	–	262
2020 Q4	$312K	Sell	3,421 -382	-10%	-$31.7K	0.07%	182
2020 Q3	$304K	Sell	3,803 -10,801	-74%	-$843K	0.08%	177
2020 Q2	$1.01M	Buy	14,604 +2,994	+26%	+$213K	0.27%	68
2020 Q1	$730K	Buy	11,610 +558	+5%	+$40.2K	0.24%	71
2019 Q4	$860K	Buy	11,052 +660	+6%	+$51.5K	0.21%	80
2019 Q3	$762K	Sell	10,392 -480	-4%	-$33.7K	0.23%	68
2019 Q2	$669K	Sell	10,872 -31,419	-74%	-$1.9M	0.19%	84
2019 Q1	$2.7M	Buy	+42,291	New	+$2.41M	0.61%	47
2016 Q4	–	Sell	-118,779	Closed	-$4.77M	–	137
2016 Q3	$4.77M	Sell	118,779 -1,416	-1%	-$53.3K	1.07%	32
2016 Q2	$4M	Buy	120,195 +276	+0.2%	+$9.44K	0.91%	34
2016 Q1	$3.53M	Buy	119,919 +4,437	+4%	+$122K	0.8%	36
2015 Q4	$3.04M	Buy	115,482 +978	+0.9%	+$25.4K	0.69%	44
2015 Q3	$2.71M	Hold	114,504	–	–	0.65%	44
2015 Q2	$2.72M	Buy	114,504 +102	+0.1%	+$2.3K	0.61%	54
2015 Q1	$2.72M	Buy	+114,402	New	+$2.57M	0.59%	55

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Strategy Asset Managers's EW Position: Q1 2021 in Review

Strategy Asset Managers sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 3,421 shares — an estimated $312K sold.

Strategy Asset Managers first reported a position in EW in Q1 2015 and held it in 15 quarters. The position peaked at $4.77M in Q3 2016. 1,144 funds tracked by Wall St. Rank hold EW as of Q1 2021.

Strategy Asset Managers reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
Strategy Asset Managers sold 3,421 Edwards Lifesciences shares in Q1 2021, an estimated $312K.
Strategy Asset Managers first reported a position in Edwards Lifesciences in Q1 2015 and held it in 15 quarters.
Strategy Asset Managers's Edwards Lifesciences position peaked at $4.77M in Q3 2016.
1,144 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on Strategy Asset Managers's 13F filing for Q1 2021, filed 12 May 2021.